Akt is a protein serine/threonine kinase that is involved in the regulation of diverse cellular processes. Phosphorylation of Akt at regulatory residues Thr-308 and Ser-473 leads to its full activation. The protein phosphatase 2A (PP2A) has long been known to negatively regulate Akt activity. The PP2A holoenzyme consists of the structural subunit (A), catalytic subunit (C), and a variable regulatory subunit (B). Here we report the identification of the specific B regulatory subunit that targets the PP2A holoenzyme to Akt. We found endogenous association of PP2A AB55C holoenzymes with Akt by co-immunoprecipitation analyses in pro-lymphoid FL5.12 cells. Akt was shown to associate with ectopically expressed B55␣ subunit in NIH3T3 cells. The direct interaction between B55␣ subunit and Akt was confirmed using in vitro pulldown analyses. Intriguingly, we found that overexpression of B55␣ subunit significantly impaired phosphorylation at Thr-308, but to a lesser extent at Ser-473 of Akt in both FL5.12 and NIH3T3 cells. Concomitantly, phosphorylation of a subset of Akt substrates, including FoxO3a, was substantially decreased by B55␣ overexpression in these cells. Silencing of B55␣ expression markedly increased phosphorylation at Thr-308 but not at Ser-473 in both FL5.12 cells and NIH3T3 cells. Consistently, PP2A AB55␣C holoenzymes preferentially dephosphorylated phospho-Thr-308 rather than phospho-Ser-473 in in vitro dephosphorylation assays. Furthermore, B55␣ overexpression retarded proliferation of NIH3T3 cells, and knockdown of B55␣ expression increased survival of FL5.12 cells upon interleukin-3 deprivation. Together, our data demonstrate that B55␣-dependent targeting of the PP2A holoenzyme to Akt selectively regulates Akt phosphorylation at Thr-308 to regulate cell proliferation and survival.
ing glucose metabolism, cell growth, cell proliferation, angiogenesis, and apoptosis (1) (2) (3) (4) (5) (6) (7) . Deregulated Akt activity has been linked to the formation of various human malignancies such as gastric adenocarcinoma, ovarian cancer, breast cancer, and thyroid cancer (5, 7, 8) . Akt is a crucial signal transducer downstream of phosphatidylinositide 3Ј-OH kinase (PI3K) that is activated upon ligand and receptor engagement on the cell surface. The Akt family consists of three major isoforms, Akt1/ PKB␣, Akt2/PKB␤, and Akt3/PKB␥, that have conserved functional domains, including an N-terminal pleckstrin homology domain, a central kinase domain, and a C-terminal regulatory domain. Recruitment of Akt to the plasma membrane upon activation of PI3K results in a conformational change, and phosphorylation of Thr-308 and Ser-473 after membrane recruitment of Akt leads to full activation of Akt (6, 9) . Akt activation is tightly controlled by counteraction of phosphatases, and tensin homologue deleted on chromosome 10 (PTEN) (10) , protein phosphatase 2A (PP2A) (11) (12) (13) (14) (15) (16) , and pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP) (17) was reported to regulate Akt activity.
It has long been known that PP2A negatively regulates Akt activity in various systems. PP2A holoenzymes consist of a dimeric core enzyme, which includes the catalytic subunit C, the structural subunit A, and a variable regulatory subunit B (18 -20) . Multiple families and isoforms of the regulatory subunit B increase the diversity of the PP2A holoenzymes. There are at least four subfamilies of the regulatory subunit, including B (B55 or PR55) (21) (22) (23) (24) , BЈ (B56 or PR61) (25, 26) , BЉ (PR72) (27) , and Bٞ (PR93/PR110) (28) . It is thought that the diverse regulatory subunits dictate substrate specificity and subcellular localization of PP2A.
Signaling modules composed of PP2A and variable kinases have been identified and are believed to increase the fidelity of signaling transduction process. The kinases that have been found to interact with PP2A include calcium-calmodulin-dependent protein kinase IV (29) , p70 S6 kinase (30, 31) , p21-activated kinases (30) , p38 kinase (32) , casein kinase II (33) , IB kinases (34, 35) , mitogen-activated protein kinase (MAPK) (36, 37) , and Akt (15, 38 -41) . Although it remains unclear whether B regulatory subunits are involved in the interactions between these kinases and PP2A, several reports using overexpression and RNA interference approaches have demonstrated the roles of the B55 regulatory subunits (42) (43) (44) and the B56 subunits (45) in the MAPK signaling pathway in multiple systems. Two reports have suggested the involvement of the B56 family in regulating Akt phosphorylation (43, 46) . Intriguingly, cells expressing a mutant A␣ subunit with selective B56 subunit binding deficiency showed decreased phosphorylation of Akt (43) . IEX, an early response gene involved in survival and proliferation, was shown to increase Akt phosphorylation by inhibiting B56-containing PP2A holoenzymes via an extracellular signal-regulated kinase (ERK)-dependent manner (46) . Here we report the identification of B55␣ as an Akt-targeting regulatory subunit of PP2A. Importantly, we demonstrate that B55␣ preferentially targets the PP2A holoenzyme to dephosphorylate Akt at Thr-308 rather than Ser-473 both in cells and in vitro, indicating substrate (site) specificity determined by the specific PP2A B regulatory subunit at the intramolecular level. Furthermore, consistent with the regulatory activity on ERKs and Akt signaling pathways, we demonstrate that B55␣ plays roles in regulating cell proliferation and survival.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents-Antibodies employed include the following: anti-phospho-Akt Ser-473, anti-phospho-Akt Thr-308, anti-phospho-ERK1/2 (Thr-202/Tyr-204), anti-HA, pan-anti-phospho-(Ser/Thr) Akt substrate, anti-phospho-FoxO1/3a (Thr-24/Thr-32), and anti-PP2A/B from Cell Signaling; and anti-PP2A/A from Santa Cruz Biotechnology; anti-PP2A/B clone 2G9 from Upstate; anti-Akt and anti-PP2A/C from BD Transduction Laboratories; anti-GSK from Santa Cruz Biotechnology; anti-GST from GE Healthcare; and anti-B56␥3 from Novus. Serine/threonine phosphatase inhibitors and okadaic acid (OA) were from Alexis Biochemicals, and microcystin-LR was from Calbiochem. Protease inhibitors, phenylmethylsulfonyl fluoride (PMSF), aprotinin, leupeptin, bacterial protease inhibitor mixture, anti-␤-actin, anti-FLAG M2 antibodies, and anti-FLAG M2-agarose were from Sigma. The specific anti-B55␦ antibody was kindly provided by Dr. Brian Wadzinski (Vanderbilt University, Nashville, TN).
DNA Constructs and Retrovirus Preparation-The fulllength human Akt1 cDNA with a C-terminal FLAG tag was prepared by PCR using a template of human Akt1 (kindly provided by Dr. P. C. Lin, Vanderbilt University, Nashville, TN) and was subsequently cloned into the bacterial expression vector pQE30 and the retroviral pMSCVpuro vector (Clontech). The C-terminal HA-tagged rat B55␣ and human B56␥3 were prepared by PCR using the pCEP4B55␣ and pCEP4B56␥3, respectively, as a template (kindly provided by Dr. David Virshup, University of Utah, Salt Lake City) and were subsequently cloned into the retroviral pMSCVpuro vector and the bacterial expression pGEX4T-1 vector (GE Healthcare). The sequence encoding short hairpin RNA (shRNA) targeting B55␣ was synthesized as two complementary oligonucleotides as described before (44) , which were subsequently phosphorylated, annealed, and ligated into the pSUPERretropuro vector (47) . The retroviral expression vectors, pMSCVpuro and pSUPERretropuro, harboring Akt cDNA, B55␣ cDNA, B56␥3 cDNA, or B55␣ shRNAencoding sequence, were transfected into BOSC23 cells by the calcium phosphate method, and viral supernatants were prepared by collecting the BOSC23 culture media 48 h after transfection and centrifugation at 1,500 rpm for 5 min.
Cell Culture-FL5.12 cells were cultured in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum and interleukin 3 (IL-3) as described before (48) . NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum (BS). BOSC23 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. In serum stimulation experiments, NIH3T3 cells were grown in medium containing 0.5% BS for 14 -16 h and were stimulated with 10% BS-containing medium. In IL-3 deprivation experiments, FL5.12 cells were grown in medium without IL-3 for 3 h and then stimulated with medium containing IL-3. In IL-3-dependent survival assay, cells were deprived of IL-3 for 24 h. In proliferation assays, NIH3T3 cells stably carrying vector or expressing B55␣HA were seeded onto 24-well plates, and cell numbers were directly counted. Viability was measured by trypan blue exclusion.
Selection of Cells Stably Expressing FLAG-tagged Akt, FLAGtagged B55␣, HA-tagged B55␣, HA-tagged B56␥3, B55␣ shRNA, or Vector Only-The cells stably expressing genes of interest were created by retroviral infection and subsequent drug selection. Cells were infected with retroviruses for 2 days and then selected with puromycin at 5 g/ml. Cells stably expressing FLAG-tagged Akt, FLAG-tagged B55␣, HA-tagged B55␣, HAtagged B56␥3, B55␣ shRNA, or vector only were isolated after a 2-day drug selection and characterized by immunoblotting for specific gene expression.
Immunoblotting and Immunoprecipitation-Cell lysates for immunoblotting were prepared in radioimmunoprecipitation assay buffer (10 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% SDS, 50 mM Tris-Cl, pH 8.0, and 1 mM EDTA) containing 1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin, 5 mM EGTA, 5 mM EDTA, 10 mM NaF, 1 M microcystin, and 1 mM Na 3 VO 4 . Cell lysates for immunoprecipitation were prepared as described before (49) with some modifications. Cells were lysed in hypotonic buffer A (10 mM Tris-Cl, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM EDTA, 1 mM EGTA) supplemented with 1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin, followed by sonication. The lysates were then subjected to centrifugation at 1000 ϫ g for 5 min. The supernatant was then adjusted to isotonic osmolarity by adding 1/10 volume of buffer B (1.4 M KCl, 30 mM MgCl 2 ). Immunoprecipitation assays were carried out using control IgG or a specific antibody in isotonic buffer, as described above, and precipitated using protein A/GSepharose. The immune complexes were then washed with wash buffer (isotonic buffer plus 0.2% Triton X-100) three times and were subjected to SDS-PAGE and immunoblotting. Immunoblots were developed using enhanced chemiluminescence. Results were quantified by densitometry using Alpha Innotech AlphaImager.
In Vitro Akt Dephosphorylation Assay-NIH3T3 cells expressing FLAG-tagged Akt were serum-starved for 16 h and stimulated with 10% BS for 5 min. Cells were lysed in the immu-noprecipitation buffer as described above without phosphatase inhibitors, and FLAG-tagged Akt was immunoprecipitated using anti-FLAG-agarose. The PP2A-B55␣ holoenzymes were prepared from NIH3T3 cells expressing FLAG-tagged B55␣ by immunoprecipitating FLAG-tagged B55␣ immunocomplexes using anti-FLAG-agarose. The FLAG-tagged Akt or B55␣ immunocomplexes were then resuspended in the phosphatase assay buffer (20 mM imidazole, 150 mM NaCl, 14.4 mM ␤-mercaptoethanol, 1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin). Aliquots of Akt immunocomplexes were then mixed with various amounts of B55␣ immunocomplexes preincubated with or without 100 nM OA for 10 min at 4°C and incubated at 30°C for 30 min. Dephosphorylation reactions were terminated by adding 4ϫ SDS sample buffer and boiling for 5 min. Results were quantified by densitometry using Alpha Innotech AlphaImager. Percentages of reduction of phosphorylation were calculated by subtracting the relative phosphorylation of reactions containing PP2A-B55␣ from 100 (control reactions with no addition of PP2A-B55␣ complexes were set as 100%), and the values were further normalized by relative amounts of pulled down C subunits (Thr(P)-308 versus Ser(P)-473) in individual reactions within a set input of PP2A-B55␣ complexes.
Recombinant Proteins-Bacterial expression constructs employed include pQE30-His 6 -Akt-FLAG, pGEX-4T-1-B55-HA, pGEX-4T-PP2A/A (a gift from Dr. Kerry Campbell, Fox Chase Cancer Center, Philadelphia), and pGEX-4T-1-PP2A/C. Each individual expression construct was transformed into Escherichia coli BL21 cells. Appropriate antibiotics were applied to select bacteria carrying the expression constructs. Isopropyl ␤-D-thiogalactopyranoside was added at various concentrations (0.2 to 1 mM) to induce the optimal expression of the recombinant proteins. The bacterial culture was pelleted and resuspended in lysis buffer (phosphatebuffered saline with 1% Triton X-100 and 1% Tween 20 for GST fusion clones, and 50 mM Na 2 HPO 4 , 300 mM NaCl, 10 mM imidazole for His-tagged clones) containing 1 mg/ml lysozyme, and a bacterial protease inhibitor mixture (Sigma). GST fusion protein was purified with glutathione-Sepharose 4B (GE Healthcare) under native conditions following the manufacturer's protocols. His-tagged protein was purified with nickel-nitrilotriacetic acid resin (Qiagen) under native conditions following the manufacturer's protocols.
In Vitro Pulldown Analysis-For analyzing in vitro interactions of individual PP2A subunits and Akt, 2 g of purified recombinant GST-PP2A/A, GST-PP2A/B, or GST-PP2A/C protein were incubated with 2 g of purified recombinant His-tagged Akt for 4 h at 4°C. GST fusion proteins were pulled down by glutathioneSepharose 4B, washed three times with wash buffer (20 mM Tris-Cl, pH 7.5, 140 mM NaCl, 1 mM CaCl 2 , 0.2% Triton X-100), fractionated by SDS-PAGE, and analyzed by immunoblotting with anti-Akt or anti-GST antibody.
RESULTS

Akt Is Associated with PP2A AB55␣C Holoenzyme Complexes-
We addressed the role of B regulatory subunits in bridging the association between PP2A and Akt in the signaling module by exploiting two systems, serum-dependent NIH3T3 cells and interleukin-3 (IL-3)-dependent FL5.12 lymphoid cells. NIH3T3 cells are highly transfectable and easily activate Akt by serum stimulation. The IL-3-dependent FL5.12 lymphoid cell represents one of cytokine-dependent hematopoietic cells in which the PI3K/Akt pathway is crucial to cellular survival (50, 51) . In FL5.12 cells, treatment with the protein phosphatase inhibitor OA at 250 nM that was shown to selectively inhibit PP2A (48) resulted in significantly increased phosphorylation of Akt at Thr-308, and to a lesser extent at Ser-473 (Fig. 1A) , suggesting that PP2A constantly regulated phosphorylation of Akt in FL5.12 cells. We then explored the possible involvement of a specific PP2A holoenzyme in regulating Akt activity in FL5.12 cells. The B55/PR55 family was shown to be widely expressed and displaced from the PP2A holoenzyme by the DNA tumor virus SV40 small T antigen (52, 53) , which activates Akt (54 -56) . We immunoprecipitated endogenous B55 by a pan-anti-B55 antibody from the FL5.12 cells and examined the association of Akt in the immunoprecipitated complexes. Significantly, Akt was co-immunoprecipitated with B55 subunits (Fig. 1B) , and as expected, A and C subunits were also co-immunoprecipitated with B55 subunits (Fig. 1B) . Because the pan-anti-B55 antibody preferentially reacts with the ␣ isoform, we next investigated the possible association of PP2A AB55␣C holoenzyme (hereafter referred to as PP2A-B55␣ holoenzyme) with Akt. HA-tagged B55␣ (B55␣⌯〈) was ectopically expressed in NIH3T3 cells and subsequently pulled down by anti-HA antibody. Co-immunoprecipitation analyses of B55␣⌯〈-associated complexes revealed that endogenous Akt was co-immunoprecipitated with PP2A-B55␣ holoenzymes in cells expressing B55␣HA but not in parental NIH3T3 cells (Fig. 1C ). In addition, the endogenous A (PP2A/A) and C subunits (PP2A/C) were co-immunoprecipitated with the exogenous B55␣⌯〈 (Fig. 1C) , indicating that the B55␣⌯〈 associates with endogenous AC core enzyme and forms an AB55␣⌯〈 holoenzyme complex. Furthermore, it was not clear whether B55␣ has the ability to directly associate with Akt and targets PP2A holoenzyme to Akt. We addressed this issue with in vitro interaction assays using bacterially expressed recombinant proteins. Recombinant GST, GST-fused PP2A/A␣, PP2A/ B55␣, or PP2A/C␣ proteins were incubated with recombinant His-tagged Akt proteins and pulled down using glutathioneSepharose. The results (Fig. 2) showed that His-tagged Akt proteins were pulled down with GST-fused B55␣ proteins by glutathione-Sepharose but not with control GST, GST-PP2A/A␣, or GST-PP2A/C␣ proteins. These data demonstrate that B55␣ subunit directly targets the PP2A-B55␣ holoenzyme to interact with Akt.
The PP2A-B55␣ Holoenzyme Preferentially Regulates the Phosphorylation of Akt at Thr-308 Downstream of IL-3 Stimulation in FL5.12 Cells-Given that the PP2A-B55␣ holoenzyme interacts with Akt, we investigated the impact of this association on Akt phosphorylation. Akt achieves its full activity through phosphorylation at both Thr-308 and Ser-473 upon stimulation by growth factors or cytokines (57, 58). We investigated whether overexpression of B55␣ could down-regulate activation of Akt upon IL-3 stimulation in FL5.12 cells. Control or B55␣HA-overexpressing FL5.12 cells (level of overexpression shown in Fig. 3A , right) were first withdrawn from IL-3 for 3 h and were replenished with IL-3-containing medium. Cells were then harvested, and lysates were prepared at various time points after IL-3 repletion. As shown in Fig. 3A , IL-3-stimulated phosphorylation of Akt peaked by 10 min after IL-3 repletion, and declined to near basal level within 30 min of stimulation. At 10 min after IL-3 stimulation, phosphorylation at Thr-308 was substantially reduced in cells overexpressing B55␣, from 12.2-to 6.93-fold of control at time 0 (Fig. 3A, left) . However, there was only modest reduction of phosphorylation at Ser-473 in cells overexpressing B55␣ compared with control cells, at 10 min after IL-3 stimulation, from 11.6-to 9.73-fold of control at time 0 (Fig. 3A, left) . Next, we silenced endogenous B55␣ expression by shRNA specifically targeting B55␣ mRNA in FL5.12 cells. When the knockdown of B55␣ reached close to 50% (Fig. 3B) , the level of phosphorylation of Thr-308 was markedly increased, whereas no increase in phosphorylation of Ser-473 was detected (Fig. 3C ). This impact did not result from nonspecific knockdown of either A or C subunit or other forms very similar to B55␣, such as the B55␦ subunit, which showed no detectable reduction (Fig. 3B) . These data suggest that the B55␣ subunit selectively targets the PP2A holoenzyme to regulate phosphorylation of Thr-308 rather than Ser-473 in FL5.12 cells.
The PP2A-B55␣ Holoenzyme Preferentially Regulates Phosphorylation of Akt at Thr-308 in Serum-stimulated NIH3T3 Cells-To examine whether the PP2A-B55␣ holoenzyme regulation of Akt Thr-308 phosphorylation is unique to lymphoid cells, we compared the level of serum-stimulated Akt phosphorylation in NIH3T3 cells overexpressing B55␣ to that of cells carrying vector only. NIH3T3 cells were serum-starved for 16 h and then re-grown in medium containing 10% bovine serum. Cells were harvested and lysates prepared at various time points after serum replacement. Consistent with the finding in FL5.12 cells, we found that the increase in phosphorylation of Thr-308 was significantly dampened in cells overexpressing B55␣ at each time point compared with control cells (Fig. 4A) . On the other hand, phosphorylation of Ser-473 in B55␣-overexpressing cells was modestly reduced compared with control cells at most time points following serum stimulation. Next, we examined the effect of shRNA-mediated B55␣ knockdown on Akt phosphorylation in NIH3T3 cells. Compared with FL5.12 cells, B55␣ knockdown was more efficient in NIH3T3 cells with near 90% efficiency (Fig. 4B) , and this may have partly resulted from lower endogenous expression of B55 family in NIH3T3 cells than in FL5.12 cells (data not shown). Consistent with the finding in FL5.12 cells, knockdown of B55␣ in NIH3T3 cells (Fig.  4B ) resulted in greater serum-stimulated phosphorylation level of Thr-308 of Akt compared with control cells (Fig. 4C) , whereas modest increase or reduction was observed in Ser-473 phosphorylation (Fig. 4C) . To investigate the uniqueness of the preferential regulation of Thr-308 phosphorylation by B55␣, we examined Akt phosphorylation in NIH3T3 cells overexpressing B56␥3, a member of the distinct B56 family. Unlike B55␣-regulated down-regulation of phosphorylation of Akt, we found that phosphorylation levels of both Thr-308 and Ser-473 were significantly enhanced by B56␥3 overexpression (Fig. 4D) . These results indicate that B55␣ preferentially targets the PP2A holoenzyme to catalyze dephosphorylation at Thr-308 of Akt but not at Ser-473 in NIH3T3 cells.
The PP2A-B55␣ Holoenzyme Preferentially Dephosphorylates Phospho-Thr-308 of Akt in Vitro-To further investigate the selectivity of the PP2A-B55␣ holoenzyme toward dephosphorylation of phospho-Thr-308, we carried out in vitro dephosphorylation of Akt in the presence of PP2A-B55␣ holoenzymes. We isolated Akt by anti-FLAG-agarose from lysates of NIH3T3 cells expressing FLAG-tagged Akt. Aliquots of isolated FLAG-Akt immunocomplexes were then incubated with various amounts of PP2A-B55␣ holoenzymes that were purified from NIH3T3 cells expressing FLAG-tagged B55␣. Immunoblottings for phospho-Thr-308 and phospho-Ser-473 of Akt of dephosphorylation reactions showed that PP2A-B55␣ holoenzymes catalyzed a dose-dependent dephosphorylation of phospho-Thr-308 but had little effect on that of phospho-Ser-473 (Fig. 5, A and B) , and that low doses of purified PP2A-B55␣ holoenzymes efficiently catalyzed dephosphorylation of phospho-Thr-308 with reduction of phosphorylation up to 66% (Fig. 5, A and  C) , whereas very modest dephosphorylation of phospho-Ser-473 (16%) was observed using higher doses of PP2A-B55␣ holoenzymes (Fig. 5, B and C) . The dephosphorylation of Thr-308 in the in vitro reactions was specifically carried out by PP2A activity because the phosphorylation of Thr-308 was restored in the presence of PP2A-selective inhibitor OA (Fig. 5D) . Taken together, our data indicate that the PP2A-B55␣ holoenzyme preferentially dephosphorylates phospho-Thr-308 of Akt in cells and in vitro. ) were deprived of IL-3 for 3 h and restimulated with IL-3. Cell lysates were collected at the times indicated after IL-3 stimulation and analyzed by SDS-PAGE and immunoblotting by specific antibodies for phospho-Akt Thr-308, phospho-Akt Ser-473, and total Akt. Representative blots from two similar experiments are shown. The levels of Akt phosphorylation were quantified by densitometry and normalized with total Akt. The data were expressed as fold increase in phosphorylation stimulated by IL-3 over control cells carrying vector alone at time 0. The fold of Akt phosphorylation to total Akt of control cells with vector alone at time 0 was set as 1. A, right, the lysates of FL5.12 cells with vector or exogenous B55␣⌯〈 overexpression were immunoblotted for expression of B55␣⌯〈 by antibodies against HA peptide, B55␣, and ␤-actin as a loading control. B, lysates of FL5.12 cells carrying pSUPERretro vector alone or pSUPERretro B55␣ shRNA were immunoblotted for PP2A A, B55␣, B55␦, and C subunits and ␤-actin. C, lysates of FL5.12 cells carrying pSUPERretro vector alone or pSUPERretro B55␣ shRNA were immunoblotted for phospho-Akt Thr-308, phosphoAkt Ser-473, and total Akt. The levels of Akt phosphorylation were quantified by densitometry and normalized with total Akt. The fold of Akt phosphorylation to total Akt of control cells with vector alone was set as 1.
Increased B55␣ Expression Modulates the Phosphorylation of
Akt Substrates-Because the PP2A-B55␣ holoenzyme preferentially down-regulates Akt Thr-308 phosphorylation, we tested whether overexpression of B55␣ influences phosphorylation of Akt substrates. FoxO1/3a transcription factors are known Akt substrates involved in regulating cell growth and survival (59, 60) . We found a substantial reduction in the phosphorylation level of FoxO3a, and to a less extent in that of FoxO1, following IL-3 or serum stimulation in B55␣-overexpressing FL5.12 ( Fig. 6A ) or NIH3T3 cells (Fig. 6B) , respectively. In addition, a pan-Akt phospho-substrate antibody that recognizes consensus Akt phosphorylation sites was used to detect the global impact of B55␣ overexpression on phosphorylation of substrates of Akt. As expected, this antibody detected increased phosphorylation of a panel of protein bands following IL-3 or serum stimulation in FL5.12 ( Fig. 6C ) or NIH3T3 cells (Fig. 6D) , respectively. Significantly, at later time points of stimulation, phosphorylation levels of a subset of potential Akt substrates were reduced by B55␣ overexpression in FL5.12 ( Fig. 6C) or NIH3T3 cells (Fig. 6D) . Furthermore, we found a modest decrease of the phosphorylation of glycogen synthase kinase-3␣ or -␤ (GSK-3␣/␤), a known immediate downstream substrate of Akt in serum-stimulated NIH3T3 cells overexpressing B55␣ (Fig. 6E) . In contrast, NIH3T3 cells overexpressing B56␥3 showed a significantly increased serumstimulated phosphorylation in GSK-3␤ (Fig. 6E) . These data suggest that B55␣ directly regulates Akt activity and modulates a subset of signaling molecules downstream of Akt.
The PP2A-B55␣ Holoenzyme Regulates Cell Proliferation and Survival-Variable B subunits have been shown to both positively and negatively regulate the MAPK signaling cascade (42, 44, 61) ; however, their role in the control of cell proliferation and survival remains unclear (62) . Our data demonstrated that PP2A-B55␣ holoenzyme was involved in regulation of Akt activity, and this prompted us to investigate the role of PP2A-B55␣ holoenzyme in cell proliferation and survival. The growth curve of a pool of NIH3T3 cells stably expressing B55␣ was compared with that of cells carrying vector only, and results (Fig. 7A) showed that numbers of B55␣-overexpressing cells were reduced to nearly 75% that of control cells by day 5. The retardation in NIH3T3 cell proliferation by B55␣ overexpression was probably not attributable to an increase in cell death because we did not find significant differences in trypan blue exclusion between cells overexpressing B55␣ and cells carrying vector only (Fig. 7B) . We also compared the survival of a pool of FL5.12 cells overexpressing B55␣ and a pool of FL5.12 cells stably expressing shRNA for knockdown of endogenous B55␣ to control FL5.12 cells carrying vector alone. After withdrawal of IL-3 for 24 h, no differences in viability were found between B55␣-overexpressing pool (Fig. 7C ) and control cells; however, cell death was significantly reduced in cells with B55␣ knockdown (Fig. 7C) . These data suggest that the PP2A-B55␣ holoenzyme plays roles in regulating cell proliferation and survival.
DISCUSSION
We have identified B55␣ as a regulatory subunit targeting the PP2A holoenzyme to regulate Akt phosphorylation as evidenced by physical association, down-regulation of Akt phosphorylation by expression of exogenous B55␣ gene, and increased Akt phosphorylation by knockdown of endogenous B55␣ gene expression. Intriguingly, the B55␣ targeting of the PP2A holoenzyme to Akt is more selective toward phosphorylated Thr-308 than phosphorylated Ser-473. Our study not only demonstrates that a specific PP2A holoenzyme complex regulates Akt activity but also provides evidence of intramolecular substrate (site) specificity regulated by the B subunit of PP2A. Furthermore, our data demonstrate that the PP2A-B55␣ holoenzyme plays roles in regulating cell proliferation and survival.
More Than One Phosphatase Regulating Akt-Our data demonstrate that the PP2A-B55␣ holoenzyme preferentially regulates phosphorylated Thr-308 of Akt in both serum-and IL-3-FIGURE 5. The PP2A AB55␣C holoenzyme selectively dephosphorylates phospho-Thr-308 of Akt in vitro. In vitro dephosphorylation reactions were carried out with aliquots of immunoprecipitated Akt incubated with increasing amounts of B55␣ immunocomplexes (0, 10, 20, and 40% of total pulldowns in lanes 1-4, respectively) as described under "Experimental Procedures." Immunoblotting for expression of phospho-Akt Thr-308 (A), phospho-Akt Ser-473 (B), Akt-FLAG, B55␣-FLAG, PP2A A and C subunits in reactions was performed by specific antibodies as described earlier. The levels of Akt phosphorylation were quantified by densitometry and normalized with total Akt. Levels of control reactions with no addition of PP2A-B55␣ complexes were set as 100%. Data expressed as percentages of reduction of phosphorylation of Akt in individual reactions in the presence of PP2A-B55␣ complexes were obtained as described under "Experimental Procedures." C, representative blots and averages of quantified results from three independent experiments are shown. D, dephosphorylation reactions of Akt in the presence or absence of B55␣ immunocomplexes with or without 100 nM OA preincubation were carried out as described under "Experimental Procedures." Immunoblotting for expression of phospho-Akt Thr-308, phospho-Akt Ser-473, Akt-FLAG, B55␣-FLAG in reactions were performed by specific antibodies as described earlier.
stimulated signaling pathways in two types of cells. Our data are consistent with findings of a recent report demonstrating that PHLPP, a PP2C-like phosphatase, specifically dephosphorylated Ser-473, whereas PP2A dephosphorylated Thr-308 (17) . Moreover, a report (63) implicated that PDK-1 (3-phosphoinositide-dependent protein kinase 1) was involved not only in phosphorylating Akt at Thr-308 but also in dephosphorylating Akt at Thr-308 through possible PP2A activity. Others have employed different approaches and cells to indicate the role of the BЈ/B56 family in regulating the phosphorylation of Akt (43, 46) . Although these studies did not particularly address the selectivity of the PP2A-B56 holoenzyme toward individual phosphorylated sites on Akt, the data of both reports unequivocally demonstrated that phosphorylation of Ser-473 was impaired by overexpression or knockdown of B56 members of PP2A. Although we were not able to test all B56 subunits, our data showed increased phosphorylation instead of decreased phosphorylation in both Thr-308 and Ser-473 of Akt in NIH3T3 cells overexpressing B56␥3 (Fig. 4) , suggesting that B55␣ rather than B56␥3 plays a direct role in regulating Akt phosphorylation in NIH3T3 cells. Together, it is possible that the PP2A-B55 and the PP2A-B56 holoenzymes preferentially dephosphorylate phospho-Thr-308 and phospho-Ser-473, respectively. It is also likely that various PP2A holoenzymes cooperate with PHLPP to dephosphorylate different phosphorylation sites and down-regulate Akt activity in different cells. (64, 65), and phosphorylation of Ser-473 is catalyzed by mTOR complex 2 (mTORC2) (66, 67) . On the other hand, PP2A and PHLPP (17) participate in dephosphorylation of Akt at distinct sites. Our data showed that association of PP2A-B55␣ holoenzyme with Akt occurred in FL5.12 cells in steady state (Fig. 1B) . PP2A-selective inhibitor OA treatment significantly increased Thr-308 phosphorylation but had a very modest effect on Ser-473 (Fig. 1A) . Consistent with this, very low levels of steadystate phosphorylation of Thr-308 were observed in FL5.12 cells (Fig. 3B) , and knockdown of B55␣ resulted in marked increase in phosphorylation of Thr-308. Similarly, phosphorylation of Thr-308 is usually undetectable in NIH3T3 cells in steady state (data not shown). These data indicate that phosphorylation of Akt is constitutively regulated by PP2A, and this may be attributed to a constant signaling module formed by Akt and PP2A. Furthermore, co-localization of both Akt kinases on membranes for phosphorylation of the key regulatory residues Thr-308 and Ser-473 appears to be required for full activation of Akt (6, 9) . The mechanism by which these Akt kinases and phosphatases are interwoven into the Akt regulatory module remains to be elucidated.
The Mechanism Underlying B Subunit-Determined Selective Regulation of Akt Phosphorylation at Thr-308 Rather than Ser-473-Our data and the data of others indicate more than one phosphatase regulates Akt phosphorylation. Employing ectopic expression of B55␣ and shRNA-mediated knockdown of endogenous B55␣ expression, we found that the B subunit can lead PP2A to distinguish its target sites intramolecularly. Notably, at least two different types of PP2A holoenzymes regulate phosphorylated sites of Akt based on our data and the data of others (43, 46) . How do different PP2A holoenzymes approach selective sites to catalyze dephosphorylation? The recently solved crystal structure of PP2A A␣B56␥C␣ (68, 69) has shed some light on the mechanism by which the B subunit determines substrate specificity. It was found that association of different B subunits can provide a completely different physicochemical landscape of the active site of the C subunit compared with the C subunit alone and may result in distinct docking sites for suitable targets. In agreement with this notion, the two phosphorylated residues, Thr-308 and Ser-473, are located at distinct structural motifs of Akt (70) . Thr-308 is located at the activation loop in the central kinase domain, and the Ser-473 is located at the C-terminal hydrophobic motif. Therefore, the unique motif structures around the two key phosphorylation sites of Akt may fit into the docking surface provided by the distinctly associated B subunit in the active site of C subunit.
The Impact on Downstream Akt Signaling Molecules by B55␣ Overexpression-It is known that phosphorylation at both Thr-308 and Ser-473 is required for full activity of Akt. When Thr-308 phosphorylation of Akt was impaired by B55␣ overexpression, phosphorylation of FoxO3a, a substrate of Akt and a member of the Forkhead family of transcription factors (59, 60) , was significantly down-regulated. When using a pan-antiphospho-Akt substrate antibody to analyze the global impact on Akt activity by B55␣ overexpression, we found that phosphorylation of a subset of targets of Akt was significantly reduced when B55␣ was overexpressed in both FL5.12 and NIH3T3 cells (Fig. 6) . Interestingly, some B55␣-modulated targets had molecular masses of ϳ93 kDa that are similar to FoxOs. Surprisingly, even when phosphorylation of Thr-308 was reduced significantly, the change in phosphorylation of GSK-3, the well known substrate of Akt, was modest. Our findings are consistent with recent reports that knock-out of components of mTORC2 resulted in defective phosphorylation of Ser-473, and marginally impaired (71) or even increased phosphorylation of GSK-3 (72) . Additionally, phosphorylation of a portion of Akt substrates, such as FoxO1/3a, was significantly decreased (71) . These findings indicate that Akt with defective phosphorylation, including singly phosphorylated forms, can still be partially functional and suggest that other kinases may compensate for the partial activity of Akt in phosphorylating GSK-3 in our experimental setting.
The PP2A-B55␣ Holoenzyme Monitors Cellular HomeostasisIt is known that the PP2A-B55␣ holoenzyme regulates MAPK signaling cascade, and our data demonstrate that it regulates Akt signaling pathway as well. Our data show that overexpression of B55␣ significantly reduces serum-stimulated phosphorylation of Thr-308 and retards proliferation of NIH3T3 cells, and that the cause is not because of increased cell death (Fig.  7B) . Our results indicated that only a subset of Akt substrates, such as FoxOs, were impaired in phosphorylation because of B55␣ overexpression, suggesting that impaired phosphorylation of Thr-308 by B55␣ overexpression may impact partially on the activities of Akt in NIH3T3 cells. In comparison with Akt defective in Ser-473 phosphorylation, mouse embryonic fibroblasts of rictor null mice with a defect in Ser-473 phosphorylation showed reduced growth rate and metabolic activity (72) , and mouse embryonic fibroblasts of SIN1 null mice with a defect in Ser-473 phosphorylation were more susceptible to death stimuli but had a similar growth phenotype as wild-type cells (71) . In FL5.12 cells, overexpression of B55␣ had very little effect on survival, whereas knockdown of B55␣ reduced death of FL5.12 cells. Similar to previous reports (71, 72) , it is possible that down-regulation of Thr-308 phosphorylation in our cells may not be enough to reach the threshold to turn off the prosurvival activity of Akt. It is also possible that the death caused by IL-3 withdrawal was severe enough such that overexpression of B55␣ cannot have more impact on it. On the other hand, significant increases in phosphorylation of Thr-308 in steady state (Figs. 3C and 7E) after knockdown of B55␣ expression may have set cells in a better surviving condition. Although previous studies demonstrated that B55 regulatory subunits significantly regulate the activity of ERKs (42-44), we detected only modest modulation or no effect on steady-state phosphorylation of ERKs in our systems (Fig. 7, D and E) . Nevertheless, in addition to Akt and MAPK signaling, the cellular effects of alteration of PP2A-B55␣ levels may have resulted from changes in activity of other PP2A-B55␣-regulated molecules. PP2A has been thought to regulate cellular transformation (56) and function as a tumor suppressor (20) . Our data and the data of others suggest that PP2A-B55␣ may contribute to this tumor suppressor activity by negatively regulating pathways such as the MAPK and Akt signaling to ensure normal growth of cells.
